Back to Search Start Over

Real-World Patient-Reported and Neurocognitive Outcomes in the Year After Axicabtagene Ciloleucel

Authors :
Hoogland, Aasha I.
Li, Xiaoyin
Modi, Karnav
Welniak, Taylor
Rodriguez, Yvelise
Irizarry-Arroyo, Nathaly
Oswald, Laura B.
Snider, Julia T.
Wade, Sally W.
Chavez, Julio
Corallo, Salvatore
Booth-Jones, Margaret
Jain, Michael D.
Locke, Frederick L.
Jim, Heather S.L.
Source :
Transplantation and Cellular Therapy; 20250101, Issue: Preprints
Publication Year :
2025

Abstract

•Quality of life generally improved in the first year after axi-cel.•Perceived cognition did not change over time.•Despite transient declines, neurocognition generally improved by day 360.•Visuospatial abilities declined by day 90 with little change thereafter.

Details

Language :
English
ISSN :
26666375 and 26666367
Issue :
Preprints
Database :
Supplemental Index
Journal :
Transplantation and Cellular Therapy
Publication Type :
Periodical
Accession number :
ejs68431456
Full Text :
https://doi.org/10.1016/j.jtct.2024.12.020